DCF — SOUTHEASTHEALTH
Enterprise Value: $-772.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-772.2M
Enterprise Value
$-239.7M
PV of Cash Flows
$-532.6M
PV of Terminal Value
$-857.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $345.3M | $-50.6M | -15.0% | $-65.3M | $-59.3M |
| Year 2 | $355.7M | $-48.6M | -14.0% | $-63.7M | $-52.6M |
| Year 3 | $366.3M | $-46.4M | -13.0% | $-61.9M | $-46.5M |
| Year 4 | $377.3M | $-45.9M | -12.0% | $-61.9M | $-42.3M |
| Year 5 | $388.6M | $-46.3M | -12.0% | $-62.8M | $-39.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-772.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$335.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.15164871877548114
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5